The BU Amyloidosis Center is an internationally recognized referral clinic and research laboratory focusing on systemic amyloidosis. The Center has been at the forefront of basic and clinical research into these rare but deadly diseases for over 50 years.
Collections in this community
(MDPI, 2021-06-11)Inhibition of amyloid fibril formation could benefit patients with systemic amyloidosis. In this group of diseases, deposition of amyloid fibrils derived from normally soluble proteins leads to progressive tissue damage ...